You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Novartis
since
auto-detected in 19 stories
3 hours ago
Novartis is the second drug company to settle a lawsuit brought by the family of a woman whose cells have enabled huge advances in science.
34 hours ago
Novartis, Genentech file suit alleging illegal importation of prescription drug ⊖
Novartis and Genentech are suing a U.S. company and a Canadian pharmacy over the importation of a Canadian version of their allergy medicine.
38 days ago
Novartis could have a U.S. deal that shields it from tariffs, CEO tells CNBC ⊖
The continent's pharma sector could be one of its worst hit by Trump's latest tariffs on some European countries.
3 months ago
Novartis targets 5%-6% annual sales growth until 2030 on key cancer drugs ⊕
Novartis said its eight most promising approved drugs each carry peak-sales potential of $3 billion to $10 billion.
4 months ago
Novartis CEO says pharma giant has the firepower for big M&A deals: 'Can never be done' ○
Novartis "can never be done" when it comes to major acquisitions in its sector, CEO Vas Narasimhan told CNBC.
Novartis set to buy Avidity Biosciences for more than $10bn ○
found
a story from Financial Times ✅ › Financial Times
Deal would be biggest acquisition under chief executive Vas Narasimhan
Novartis is in talks to buy U.S. biotech firm Avidity Biosciences for more than $70 a share, Bloomberg News reports ⊕
found
Swiss pharmaceutical giant Novartis is nearing a deal to buy biotechnology company Avidity Biosciences for more than $70 a share, Bloomberg News reported.
5 months ago
How Novartis got ahead on ‘incredible’ cancer breakthrough ○
Swiss pharma group has become a pioneer in radioligand therapy, a new type of targeted radiotherapy
Cholesterol-busting jab given twice a year could transform heart care, its maker says ○
It comes as new trial data suggests Leqvio, also known as inclisiran and made by Novartis, helped patients meet their cholesterol goals faster than other therapies.
6 months ago
NHS to lose out on new drugs due to skyrocketing costs, pharma firm warns ○
The claims from pharmaceutical giant Novartis comes amid a row over drug pricing deals.